Blackstone Group closed its inaugural life sciences fund, Blackstone Life Sciences V (BXLS V), at its hard cap of $4.6 billion, making it the largest life sciences private fund raised till date.

Blackstone Life Sciences (BLS) invests in established life science companies, finances late-stage products, and makes growth investments in emerging life-science compani